23 related articles for article (PubMed ID: 6957513)
1. Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.
Koehler BC; Jäger D; Schulze-Bergkamen H
World J Gastroenterol; 2014 Feb; 20(8):1923-34. PubMed ID: 24587670
[TBL] [Abstract][Full Text] [Related]
2. Reduced hepatic sterol carrier protein-2 expression in the streptozotocin treated diabetic rat.
McLean MP; Nanjo K; Irby RB; Warden KJ; Billheimer JT
Endocrine; 1995 Aug; 3(8):563-71. PubMed ID: 21153133
[TBL] [Abstract][Full Text] [Related]
3. Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats.
Martins IJ; Sainsbury AJ; Mamo JC; Redgrave TG
Diabetologia; 1994 Mar; 37(3):238-46. PubMed ID: 8174836
[TBL] [Abstract][Full Text] [Related]
4. Diurnal rhythm of HMG CoA reductase activity in canine intestine is independent of luminal contents.
Gebhard RL; Sievert CE; Prigge WF
Lipids; 1986 Jun; 21(6):420-1. PubMed ID: 3736353
[TBL] [Abstract][Full Text] [Related]
5. Copper-induced hypercholesterolemia of golden hamsters: enhanced synthesis of cholesterol in the liver.
Ohguchi S; Ichimiya H; Yagi A; Hayashi H; Sakamoto N
Gastroenterol Jpn; 1988 Dec; 23(6):629-32. PubMed ID: 3220240
[TBL] [Abstract][Full Text] [Related]
6. Morphological changes of the villous microvascular architecture and intestinal growth in rats with streptozotocin-induced diabetes.
Tahara T; Yamamoto T
Virchows Arch A Pathol Anat Histopathol; 1988; 413(2):151-8. PubMed ID: 3133874
[TBL] [Abstract][Full Text] [Related]
7. Diabetes-induced alteration of HMGCoA reductase forms in rat livers.
Magni F; Cancellieri M; Del Puppo M; Galli Kienle M
Acta Diabetol; 1992; 28(3-4):211-4. PubMed ID: 1576357
[TBL] [Abstract][Full Text] [Related]
8. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity.
Ness GC; Chambers CM
Proc Soc Exp Biol Med; 2000 May; 224(1):8-19. PubMed ID: 10782041
[TBL] [Abstract][Full Text] [Related]
9. Preventing hyperphagia normalizes 3-hydroxy-3-methylglutaryl-CoA reductase activity in small intestine and liver of diabetic rats.
Young NL; Saudek CD; Walters L; Lapeyrolerie J; Chang V
J Lipid Res; 1982 Aug; 23(6):831-8. PubMed ID: 6957513
[TBL] [Abstract][Full Text] [Related]
10. Total hydroxymethylglutaryl CoA reductase activity in the small intestine and liver of insulin-deficient rats.
Young NL; Saudek CD; Crawford SA
J Lipid Res; 1982 Feb; 23(2):266-75. PubMed ID: 7042879
[TBL] [Abstract][Full Text] [Related]
11. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine.
Feingold KR; Wilson DE; Wood LC; Kwong LK; Moser AH; Grunfeld C
Metabolism; 1994 Apr; 43(4):450-4. PubMed ID: 8159102
[TBL] [Abstract][Full Text] [Related]
12. Intestinal and hepatic cholesterogenesis in hypercholesterolemic dyslipidemia of experimental diabetes in dogs.
Kwong LK; Feingold KR; Peric-Golia L; Le T; Karkas JD; Alberts AW; Wilson DE
Diabetes; 1991 Dec; 40(12):1630-9. PubMed ID: 1756903
[TBL] [Abstract][Full Text] [Related]
13. Hyperphagia alters cholesterol dynamics in diabetic rats.
Young NL; McNamara DJ; Saudek CD; Krasovsky J; Lopez DR; Levy G
Diabetes; 1983 Sep; 32(9):811-9. PubMed ID: 6578989
[TBL] [Abstract][Full Text] [Related]
14. Influence of streptozotocin diabetes on intestinal 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in the rat.
Nakayama H; Nakagawa S
Diabetes; 1977 May; 26(5):439-44. PubMed ID: 140087
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
